Healthy Volunteers Clinical Trial
Official title:
New Technology and Child Health
Background: We are involved in testing new behavioral science methods and measures for future research projects. In the course of these evaluations, we will also test research questions related to parents psychological experiences and how these relate to the responses they have when they encounter different types of communication about child health. We are testing multiple research questions in the course of this research. Objective: - To learn about technologies and approaches to use in future research studies. Eligibility: - Parents (fathers and mothers) of children between the ages of 3-7. Design: As part of the main study, participants will do four tasks: Task 1: Before participants arrive for an in-person visit, they will answer questions online about themselves, their child, and their thoughts and opinions related to health. Task 2: At the in-person visit, participants will watch a short scene from a movie and answer some questions Task 3: At the in-person visit, participants will read information about a child health topic and answer questions Task 4: At the in-person visit, participants will use a virtual reality-based buffet restaurant simulation to make hypothetical food choices for their child
Status | Recruiting |
Enrollment | 670 |
Est. completion date | December 31, 2025 |
Est. primary completion date | December 31, 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 120 Years |
Eligibility | - INCLUSION CRITERIA - MAIN TRIAL - All participants in the main trial will be healthy adult parents 18 years and older - Inclusion criteria include: 1. being the parent of a biological child who is between 4 and 7 years old with no major allergies or dietary-related health conditions; 2. having some responsibility for child s dietary intake ; 3. having the ability to read, write, and converse in English; 4. being able to come to the NIH Clinical Center for one visit. EXCLUSION CRITERIA - MAIN TRIAL - Exclusion criteria include: 1. having received information about the study purpose; 2. being an NHGRI employee; 3. being from a family wherein another household member or co-parent of a biological child has already participated or is scheduled to participate. EXCLUSION CRITERIA - VIRTUAL REALITY - Exclusion criteria related to use of the virtual reality environment include: 1. having a medical susceptibility to dizziness, disorientation or nausea; 2. having a seizure disorder or epilepsy; 3. having a high propensity for motion sickness; 4. lacking freedom of movement; 5. known pregnancy; 6. low, uncorrected vision and hearing. INCLUSION CRITERIA - PILOT - Participants in the Pilot test will be healthy adult parents 18 years and older. - Inclusion criteria include: 1. being the parent of a biological child who is between 3 and 7 years old with no major allergies or dietary-related health conditions, but only for the first 10 participants; 2. having the ability to read, write, and converse in English; 3. being able to come to the NIH Clinical Center for one visit. EXCLUSION CRITERIA - PILOT 1. having received information about the study purpose; 2. being an NHGRI employee; 3. low, uncorrected vision and hearing. INCLUSION CRITERIA - BUFFET SERVING EVALUATION - Participants in the secondary Buffet Serving Evaluation will be healthy adult parents 18 years and older - Inclusion criteria include: 1. being the parent of a biological child who is between 3 and 7 years old with no major allergies or dietary-related health conditions; 2. having some responsibility for child s dietary intake ; 3. having the ability to read, write, and converse in English; 4. being able to come to the NIH Clinical Center for one visit. EXCLUSION CRITERIA - BUFFET SERVING EVALUATION (MAIN) 1. being an NHGRI employee; 2. being from a family wherein another household member or co-parent of a biological child has already participated or is scheduled to participate. EXCLUSION CRITERIA - BUFFET SERVING EVALUATION (VIRTUAL REALITY) - Exclusion criteria related to use of the virtual reality environment include: 1. having a medical susceptibility to dizziness, disorientation or nausea; 2. having a seizure disorder or epilepsy; 3. having a high propensity for motion sickness; 4. lacking freedom of movement; 5. known pregnancy; 6. low, uncorrected vision and hearing. INCLUSION CRITERIA- OLFACTORY AWARENESS TEST: - Participants in the Olfactory Awareness Test will be healthy adults between the ages of 18 and 59 Inclusion criteria include: 1. Having the ability to read, write and converse in English 2. Able to come to the clinical center for on visit. We may also include the following inclusion criteria: 1. Being the parent of a biological child who is between 3 and 7 years old with no major allergies or dietary-related health conditions 2. Having some responsibility for child s dietary intake; however, if we encounter recruitment difficulties, we may instead sample nonparent participants who are of the same general age range as parents who participated in our past studies using the virtual buffet. For the pilot test, we will sample non-parents in the age range of past parent participants EXCLUSION CRITERIA-OLFACTORY AWRAENESS TEST: 1. Being an NHGRI employee; 2. Having participated in the Parents TAKE study conducted previously in this lab. Exclusion criteria related to use of the virtual reality environment include: 1. Having a medical susceptibility to dizziness, disorientation or nausea; 2. Having a seizure disorder or epilepsy; 3. Having a high propensity for motion sickness; 4. Lacking freedom of movement; 5. Known pregnancy; 6. Weak, uncorrected vision, hearing, and/or smell. No adults older than age 59 will be able to participate in this study because older adults tend to experience a decline in olfactory function |
Country | Name | City | State |
---|---|---|---|
United States | National Institutes of Health Clinical Center | Bethesda | Maryland |
Lead Sponsor | Collaborator |
---|---|
National Human Genome Research Institute (NHGRI) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Exhibited emotion, Feeding decisions, self-reported attitudes, beliefs and intentions; perceptual responses | feeding behavior and self-reported outcomes | At lab visit |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05001152 -
Taste Assessment of Ozanimod
|
Phase 1 | |
Completed |
NCT05029518 -
3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability
|
Phase 1 | |
Completed |
NCT04493255 -
A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants
|
Phase 1 | |
Completed |
NCT03457649 -
IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00995891 -
Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
|
||
Completed |
NCT05050318 -
Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively
|
Phase 4 | |
Completed |
NCT05043766 -
Evaluation of Oral PF614 Relative to OxyContin
|
Phase 1 | |
Completed |
NCT04466748 -
A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects
|
Phase 1 | |
Completed |
NCT00746733 -
Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC
|
Phase 1 | |
Recruiting |
NCT05929651 -
Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy
|
Phase 4 | |
Completed |
NCT05954039 -
Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect
|
N/A | |
Completed |
NCT05045716 -
A Study of Subcutaneous Lecanemab in Healthy Participants
|
Phase 1 | |
Active, not recruiting |
NCT02747927 -
Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children
|
Phase 3 | |
Completed |
NCT05533801 -
A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants
|
Phase 1 | |
Not yet recruiting |
NCT03931369 -
Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST)
|
Phase 2 | |
Completed |
NCT03279146 -
A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects
|
Phase 1 | |
Completed |
NCT06027437 -
A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants
|
Phase 1 | |
Recruiting |
NCT05619874 -
Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity
|
N/A | |
Completed |
NCT05553418 -
Investigational On-body Injector Clinical Study
|
N/A | |
Completed |
NCT04092712 -
Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers
|
Phase 1 |